Sylvant (siltuximab) is indicated for the treatment of patients with multi-centric Castleman’s disease...
Jeuveau (prabotulinumtoxinA-xvfs) for the Treatment of Frown Lines
Jeuveau™ (prabotulinumtoxinA-xvfs) is a neurotoxin indicated for temporary improvement of moderate to severe glabellar lines, called frown lines.
Zubsolv (Buprenorphine and Naloxone) – Maintenance Treatment for Opioid Dependence
Zubsolv (buprenorphine and naloxone) is a sublingual tablet indicated as maintenance treatment for people suffering from opioid dependence.
Xhance™ (fluticasone propionate) for the Treatment of Nasal Polyps
Xhance™ (fluticasone propionate / previously known as OPN-375), a synthetic trifluorinated corticosteroid, is indicated for the treatment of nasal polyps in patients aged 18 years or older.
Defitelio (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease
Defitelio (defibrotide sodium) is an injectable drug developed by Jazz Pharmaceuticals, for the treatment of hepatic veno-occlusive disease (VOD) also known as sinusoidal obstruction syndrome, in adults and children with renal or pulmonary dysfunction following hematopoietic stem cell transplantation (HSCT).
Zohydro (Hydrocodone Bitartrate) for the Treatment of Chronic Pain
Zohydro (hydrocodone) is a single-entity oral drug indicated for the treatment of chronic pain. San Diego-based pharmaceutical company Zogenix developed and commercialised the drug in the US.
Velphoro for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis
Velphoro (sucroferric oxyhydroxide / PA21) is an iron-based Ca-free phosphate binder for treating Hyperphosphatemia in Chronic Kidney Disease (CKD) patients on dialysis.